Axena Health, Inc., a women's health company redefining the standard of care for pelvic health conditions through clinically proven, non-invasive treatments, today announced a new publication entitled ...

Pancreatic cancer is one of the deadliest cancers and among the hardest to treat, with most patients surviving less than a ...

An international clinical trial led by researchers at the Center for Addiction and Mental Health (CAMH) and University of ...

A systematic review finds limited evidence that selected drugs and hydration may reduce the risk for kidney stone recurrence.

When IVUS did not outperform angiography for guiding percutaneous interventions in two trials, the results offered more questions than answers.

Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new European study has shown that carefully designed observational studies can ...

Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study) The aim of this open-label, ...

The Phase 2b study demonstrated a statistically significant dose-response relationship at the primary endpoint following a single administration of MM120 across four dose levels, with improvements ...

Two years of daily multivitamin use was associated with slower biological aging compared with placebo in older adults, ...

Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...